Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization

Multiple Sclerosis

Volumn 11, Issue 2, 2005, Pages 227-231

  Uitdehaag, Bernard M J ^a   Kappos, Ludwig ^b   Bauer, Lars ^c   Freedman, Mark S ^d   Miller, David ^e   Sandbrink, Rupert ^c   Polman, Chris H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c BAYER PHARMA AG   (Germany)

^d UNIVERSITY OF OTTAWA   (Canada)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Diagnosis; Symptoms and signs

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DEMYELINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; STANDARDIZATION;

ADOLESCENT; ADULT; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROLOGY; RANDOMIZED CONTROLLED TRIALS;

EID: 15544380744     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1149oa     Document Type: Article

References (5)

1. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FB et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-27.
2. Polman CH, Freedman M, Hartung H, Kappos L, Miller D, Montalban X et al. Interferon beta-1b (Betaferon® /Betaseron®) in early treatment of multiple sclerosis: the BENEFIT study. Mult Scler 2003; 9: S93.
3. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001; 357: 1576-82.
4. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000; 343: 898-904.
5. Zipoli V, Portaccio E, Siracusa G, Pracucci G, Sorbi S, Amato MP. Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. Mult Scler 2003; 9: 481-85.